Cancer3D: understanding cancer mutations through protein structures

The new era of cancer genomics is providing us with extensive knowledge of mutations and other alterations in cancer. The Cancer3D database at http://www.cancer3d.org gives an open and user-friendly way to analyze cancer missense mutations in the context of structures of proteins in which they are found. The database also helps users analyze the distribution patterns of the mutations as well as their relationship to changes in drug activity through two algorithms: e-Driver and e-Drug. These algorithms use knowledge of modular structure of genes and proteins to separately study each region. This approach allows users to find novel candidate driver regions or drug biomarkers that cannot be found when similar analyses are done on the whole-gene level. The Cancer3D database provides access to the results of such analyses based on data from The Cancer Genome Atlas (TCGA) and the Cancer Cell Line Encyclopedia (CCLE). In addition, it displays mutations from over 14 700 proteins mapped to more than 24 300 structures from PDB. This helps users visualize the distribution of mutations and identify novel three-dimensional patterns in their distribution.

[1]  J. Valcárcel,et al.  Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers , 2014, Cell.

[2]  D. Haussler,et al.  Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser , 2013, Scientific Reports.

[3]  P. Hirth,et al.  Vemurafenib: the first drug approved for BRAF-mutant cancer , 2012, Nature Reviews Drug Discovery.

[4]  Jaime Prilusky,et al.  FoldIndex copyright: a simple tool to predict whether a given protein sequence is intrinsically unfolded , 2005, Bioinform..

[5]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[6]  Adam A. Margolin,et al.  Assessing the clinical utility of cancer genomic and proteomic data across tumor types , 2014, Nature Biotechnology.

[7]  Dong Xu,et al.  AIDA: ab initio domain assembly server , 2014, Nucleic Acids Res..

[8]  G. Hong,et al.  Nucleic Acids Research , 2015, Nucleic Acids Research.

[9]  J. Beckmann,et al.  FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. , 2005, Bioinformatics.

[10]  A. Valencia,et al.  Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics , 2012, Genome Medicine.

[11]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[12]  Haiyuan Yu,et al.  Three-dimensional reconstruction of protein networks provides insight into human genetic disease , 2012, Nature Biotechnology.

[13]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[14]  Adam Godzik,et al.  e-Driver: a novel method to identify protein regions driving cancer , 2014, Bioinform..

[15]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[16]  Gautier Koscielny,et al.  Ensembl 2012 , 2011, Nucleic Acids Res..

[17]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[18]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[19]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[20]  M. Vidal,et al.  Edgetic perturbation models of human inherited disorders , 2009, Molecular systems biology.

[21]  C. Sigman,et al.  Cancer biomarkers: selecting the right drug for the right patient , 2012, Nature Reviews Drug Discovery.

[22]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[23]  Thomas A. Peterson,et al.  Domain landscapes of somatic mutations in cancer , 2012, BMC Genomics.

[24]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[25]  Adam Godzik,et al.  Analysis of Individual Protein Regions Provides Novel Insights on Cancer Pharmacogenomics , 2015, PLoS Comput. Biol..

[26]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[27]  Christoph Weber,et al.  FFAS server: novel features and applications , 2011, Nucleic Acids Res..

[28]  M. Stratton,et al.  Abstract 2206: Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. , 2013 .